ArticleCase reports in oncological medicine2026

Dual Pathway Inhibition in Patients With mRCC: A Case Series From Kuwait Highlighting the Role of Avelumab and Axitinib.

Mohamed Ashour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.